Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update
Announced new U.S.-based leadership with the appointment of Barry Quart, Pharm.D. as Chief Executive Officer (CEO) and David Szekeres as President Connect’s new management is currently evaluating the future clinical development strategy for rademikibart As …